[{"Assets_0_FY_USD":719558000.0,"CommonStockSharesOutstanding_0_FY_shares":50860588.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-290566000.0,"NetIncomeLoss_4_FY_USD":-197611000.0,"NetIncomeLoss_1_FY_USD":-87826000.0,"StockholdersEquity_0_FY_USD":608908000.0,"EarningsPerShareBasic_1_FY_USD":-1.73,"Ticker":"RARE","CIK":"1515673","name":"ULTRAGENYX PHARMACEUTICAL INC.","OfficialName":"Ultragenyx Pharmaceutical Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5418950849.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190220"}]